Stroke is responsible for 1 in 19 deaths in the United States and is the leading cause of long-term disability.  Could something as simple and cheap as folic acid substantially reduce the risk of stroke?  The China Stroke Primary Prevention Trial examined this important question.

Every

health professional takes an oath to service patients. To fulfill this

covenant, patient trust must be earned. Without trust, patients are unlikely to

share sensitive, personal information, hindering the provision of optimal

care. Gaining trust is influenced by many factors. What influence does attire

have on patients’ perceptions of their healthcare providers?

The American Diabetes Association and European Association for the Study of Diabetes (ADA/EASD) guidelines acknowledge that “CSII is a less commonly used and more costly alternative” to basal-bolus therapy in patients with T2DM.  The Opt2mise was a robust study intended to clarify the role of CSII in patients with T2DM.

Our guests - Dr. Cortney Mospan and Dr. Augustus (Rob) Hough - critically examine the results of the DAPT and PEGASUS-TIMI 54 studies and explain how the results should be applied in practice.

Could a commonly prescribed antibiotic, when

combined with a renin-angiotensin system inhibitor, lead to sudden death?

The ORBIT-AF study raises questions about anticoagulation therapy bridging practices.  Do the risks outweigh the benefits?

Angling for something safer and less costly - fish oil!   But is it helpful for rheumatoid arthritis?

Demonstration projects are underway as part of the ACA’s Independence at Home (IAH) program. The goal — reduce costs.

Can deploying trained laypeople working directly with low income adults with asthma in the community improve outcomes? This is what the Home-Based Asthma Support and Education (HomeBASE) trial set out to answer.

Guidelines promote the use of statins as first line therapy to prevent atherosclerotic cardiovascular disease

events. Does adding niacin to

statin treatment reduce residual risk?